Softway Medical Group, a leading European healthcare software provider which develops, hosts, and integrates software solutions for the public and private healthcare system in France, Canada and Europe, today announced that Bain Capital’s European private equity fund intends to join its capital structure. Current French shareholders and managers, including Five Arrows and Naxicap Partners, are expected to remain invested as part of the new consortium. Financial terms of the transaction were not disclosed. It’s the fourth time since 2009 that the Group operates such an evolution of its capital structure.
Headquartered in Fuveau, close to Aix-en-Provence, Softway Medical Group offers a full suite of cloud-native solutions, including Electronic Medical Records (EMR), Patient Administration Systems (PAS), and integrated patient management tools tailored to the needs of both public and private providers. The company is a trusted partner to thousands of healthcare institutions, private and public hospitals, imaging centres, laboratories and primary care facilities and has built a track record of sustained organic growth over the past decade.
The business has started its international expansion in Belgium and Canada and is now well positioned to grow across Europe, capitalising on its modern cloud technology platform. Bain Capital Europe brings deep experience in both vertical software and global healthcare technology and will support Softway Medical Group in accelerating in its innovation journey as well as its goal of further international expansion.
Patrice Taisson, CEO of Softway Medical Group, commented, “Since Five Arrows became investors in 2020 alongside Naxicap, their unwavering support and strategic advice has been instrumental in Softway Medical Group’s journey to date. This has included fostering strategic partnerships and driving product innovations that have significantly accelerated growth. Our recent experience with Bain Capital Europe convinced us they would be the partner of choice for the next phase of the development of the Group. “
Guillaume Pascal, deputy CEO of Softway Medical Group, added, “We are excited to join forces with Bain Capital Europe. Their expertise and resources will be invaluable as we continue to expand our footprint and develop new solutions to meet the evolving needs of healthcare providers for the final benefits of patients. Their support in the acceleration of our international development and in the health data space will be of the upmost value. Together, we will drive the next phase of growth for our Group.“
Brahim Ammor, a Partner at Five Arrows, said “The Softway Medical Group team impressed us with their ambitious vision for the healthcare EHR space and exceptional track record of growth. Under Patrice’s leadership, complemented by Guillaume’s strategic direction since joining the Group, and together with their deeply committed team, the company has built a strong value proposition for healthcare professionals through innovative solutions addressing their operational needs and challenges. We are delighted to welcome Bain Capital Europe to the capital structure to support Softway Medical Group’s expansion as a trusted healthcare partner of choice.“
Eric Aveillan, Chairman of Naxicap Partners, shared: “Naxicap Partners has supported Softway Medical Group since 2009. We were immediately impressed by the bold vision of Patrice Taisson and his team. In 15 years, they have built a healthcare IT leader from the ground up widely recognized for its technology and the impact of its solutions. The investment from a fund of the quality of Bain Capital Europe is a strong endorsement of both the work accomplished and the potential of Softway Medical Group. I am confident that Bain Capital Europe is the ideal partner to take the Group to the next level and accelerate its international expansion.”
Matthias Boyer Chammard, a Partner at Bain Capital, commented, “We look forward to collaborating with the management team to propel sustainable growth and foster innovation. Our investment will support the company’s continued expansion and the enhancement of its product offerings which will ultimately improve the patient experience in France and across Europe. We acknowledge Softway Medical Group’s historical relevance to France and its shareholders, and we are committed to honouring and building upon this legacy.”
Giovanni Camera, a Partner at Bain Capital, added, “Softway Medical Group’s Europe-based, scalable and cloud-native technology platform is compelling. We are particularly excited about the potential across Europe and the introduction of new value-added solutions, which align perfectly with our investment philosophy of digitising the healthcare system in Europe.“
The signing of a definitive agreement is subject to the customary information and consultation of the relevant employee representative bodies. The transaction is expected to close in the second half of 2025, also subject to customary closing conditions and regulatory approvals.
About Softway Medical
Inspiring digital healthcare means illuminating and enabling the evolution of practices for both healthcare professionals and patients. For 25 years, we have been driven by our sharp vision of the healthcare market and its changes. We do not follow trends; we anticipate them, and sometimes even provoke them.
Through the strength of the Group, we ensure that the practices and usages of tomorrow become a reality today. In doing so, we illuminate and enable the evolution of practices, allowing healthcare professionals to be ever more efficient and patients to become actors in their own health. At Softway Medical Group, we are pragmatic visionaries.
In France, Belgium, and Canada, with over 1,200 employees, our solutions equip more than 200,000 healthcare professionals in private and public institutions, outpatient care, imaging centres, and laboratory services. As both an editor, integrator, and health data hosting provider, our unique positioning allows us to break down silos, improve the patient care pathway, and contribute to prevention for all citizens.
About Bain Capital Europe
Founded in 1984, Bain Capital is one of the world’s leading private investment firms. The firm has a significant history in Europe, starting with the establishment of a London office in 2000 and expanding to include other European locations, with a focus on private equity, credit and special situations investments.
We are committed to creating lasting impact for our investors, teams, businesses, and the communities in which we live. As a private partnership, we lead with conviction and a culture of collaboration, advantages that enable us to innovate investment approaches, unlock opportunities, and create exceptional outcomes. Our global platform invests across five focus areas: Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real Assets. In these focus areas, we bring deep sector expertise and wide-ranging capabilities.
We have 24 offices on four continents, more than 1,850 employees, and approximately $185 billion in assets under management.
To learn more, visit www.baincapital.com.
Follow @BainCapital on LinkedIn and X (Twitter).
About Five Arrows
Five Arrows is the alternative assets arm of Rothschild & Co and has more than €28 billion AuM1 with offices in Paris, London, New York, Los Angeles, San Francisco and Luxembourg. This includes a series of funds dedicated to corporate private equity; primary and secondary fund investing; co-investments; and senior and junior credit.
With over €10 billion of assets under management, the corporate private equity business of Five Arrows is focused on investing in companies with highly defensible market positions; strong management teams; business models with high visibility of organic unit volume growth and strong unit economics; and multiple operational levers that can be used to unlock latent value. Sectors are limited to data and software, technology–enabled business services, and healthcare.
For more information, please visit www.rothschildandco.com/en/five-arrows/corporate-private-equity.
[1] As of December 2024
About Naxicap Partners
As one of the top private equity firms in France, Naxicap Partners has €7.9 billion in assets under management.
As a committed, responsible investor, Naxicap Partners builds solid, constructive partnerships with entrepreneurs so that their projects can succeed. The firm has 63 investment professionals spread across five offices in Paris, Lyon, Toulouse, Nantes, Frankfurt and Zurich.
For more information, visit www.naxicap.com/en
